<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.managedhealthcareexecutive.com/view/a-conversation-about-the-challenges-and-benefits-of-hiv-testing-in-church-with-jannette-berkley-patton-ph-d-and-kathryn-derose-ph-d-</loc><lastmod>2026-06-03T19:47:00Z</lastmod><news:news><news:publication_date>2026-06-03T19:47:00Z</news:publication_date>
        <news:title><![CDATA[A conversation about the challenges and benefits of HIV testing in church, with Jannette Berkley-Patton, Ph.D., and Kathryn Derose, Ph.D.]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/new-insights-into-adhd</loc><lastmod>2026-06-03T18:46:58.649Z</lastmod><news:news><news:publication_date>2026-06-03T18:46:58.649Z</news:publication_date>
        <news:title><![CDATA[New Insights Into ADHD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/dual-target-adc-shows-promising-pfs-signal-in-mcrpc-asco-2025</loc><lastmod>2026-06-03T16:36:00.443Z</lastmod><news:news><news:publication_date>2026-06-03T16:36:00.443Z</news:publication_date>
        <news:title><![CDATA[Dual-target ADC shows promising PFS signal in mCRPC | ASCO 2025]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/340b-reform-and-drug-shortages-are-among-hospital-pharmacy-concerns-survey-finds</loc><lastmod>2026-06-03T16:05:48.475Z</lastmod><news:news><news:publication_date>2026-06-03T16:05:48.475Z</news:publication_date>
        <news:title><![CDATA[340B reform and drug shortages are among hospital pharmacy concerns, survey finds]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/healthcare-s-workforce-has-a-scale-problem-but-new-model-is-emerging</loc><lastmod>2026-06-03T13:28:00Z</lastmod><news:news><news:publication_date>2026-06-03T13:28:00Z</news:publication_date>
        <news:title><![CDATA[Healthcare’s workforce has a scale problem, but new model is emerging]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/daraxonrasib-trial-exceeds-expectations-after-decades-of-disappointment-in-pancreatic-cancer-drug-development</loc><lastmod>2026-06-03T00:22:00Z</lastmod><news:news><news:publication_date>2026-06-03T00:22:00Z</news:publication_date>
        <news:title><![CDATA[Daraxonrasib trial exceeds expectations after decades of disappointment in pancreatic cancer drug development]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/fda-approves-differin-epiduo-acne-gel-for-over-the-counter-use</loc><lastmod>2026-06-02T17:53:00Z</lastmod><news:news><news:publication_date>2026-06-02T17:53:00Z</news:publication_date>
        <news:title><![CDATA[FDA approves Differin Epiduo Acne Gel for over-the-counter use]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/brukinsa-provides-long-term-disease-control-in-chronic-lymphocytic-leukemia</loc><lastmod>2026-06-02T15:52:54.373Z</lastmod><news:news><news:publication_date>2026-06-02T15:52:54.373Z</news:publication_date>
        <news:title><![CDATA[Brukinsa provides long-term disease control in chronic lymphocytic leukemia]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/peterson-philanthropies-stands-up-health-analytics-company-for-employers</loc><lastmod>2026-06-02T13:32:53.386Z</lastmod><news:news><news:publication_date>2026-06-02T13:32:00Z</news:publication_date>
        <news:title><![CDATA[Peterson Philanthropies stands up health analytics company for employers]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/the-bispecific-era-in-multiple-myeloma-future-directions-written-recap</loc><lastmod>2026-05-18T13:00:00.000Z</lastmod><news:news><news:publication_date>2026-06-01T13:57:43.089Z</news:publication_date>
        <news:title><![CDATA[The bispecific era in multiple myeloma — Future directions: Written recap]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/lorece-shaw-pharm-d-2026-mhe-emerging-leaders-in-healthcare</loc><lastmod>2026-06-01T12:05:00Z</lastmod><news:news><news:publication_date>2026-06-01T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Lorece Shaw, Pharm.D. | 2026 MHE Emerging Leaders in Healthcare]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/alyana-samai-m-p-h-2026-mhe-emerging-leaders-in-healthcare</loc><lastmod>2026-06-01T12:04:00Z</lastmod><news:news><news:publication_date>2026-06-01T12:04:00Z</news:publication_date>
        <news:title><![CDATA[Alyana Samai, M.P.H. | 2026 MHE Emerging Leaders in Healthcare]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/zach-jones-pharm-d-2026-mhe-emerging-leaders-in-healthcare</loc><lastmod>2026-06-01T12:04:00Z</lastmod><news:news><news:publication_date>2026-06-01T12:04:00Z</news:publication_date>
        <news:title><![CDATA[Zach Jones, Pharm.D. | 2026 MHE Emerging Leaders in Healthcare]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/carly-rodriguez-pharm-d-2026-mhe-emerging-leaders-in-healthcare</loc><lastmod>2026-06-01T12:01:00Z</lastmod><news:news><news:publication_date>2026-06-01T12:01:00Z</news:publication_date>
        <news:title><![CDATA[Carly Rodriguez, Pharm.D. | 2026 MHE Emerging Leaders in Healthcare]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/brianna-oddi-pharm-d-2026-mhe-emerging-leaders-in-healthcare</loc><lastmod>2026-06-01T12:01:00Z</lastmod><news:news><news:publication_date>2026-06-01T12:01:00Z</news:publication_date>
        <news:title><![CDATA[Brianna Oddi, Pharm.D.| 2026 MHE Emerging Leaders in Healthcare]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/mike-nguyen-2026-mhe-emerging-leaders-in-healthcare</loc><lastmod>2026-06-01T12:01:00Z</lastmod><news:news><news:publication_date>2026-06-01T12:01:00Z</news:publication_date>
        <news:title><![CDATA[Mike Nguyen | 2026 MHE Emerging Leaders in Healthcare]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/mike-badome-2026-mhe-emerging-leaders-in-healthcare</loc><lastmod>2026-06-01T12:01:00Z</lastmod><news:news><news:publication_date>2026-06-01T12:01:00Z</news:publication_date>
        <news:title><![CDATA[Mike Badome | 2026 MHE Emerging Leaders in Healthcare]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/the-future-landscape-topical-vs-systemic-jak-inhibitors-in-vitiligo</loc><lastmod>2026-06-01T12:00:00Z</lastmod><news:news><news:publication_date>2026-06-01T12:00:00Z</news:publication_date>
        <news:title><![CDATA[The Future Landscape: Topical vs. Systemic JAK Inhibitors in Vitiligo]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/sj-gren-s-disease-seeking-answers-from-more-than-90-years-of-research</loc><lastmod>2026-06-01T12:00:00Z</lastmod><news:news><news:publication_date>2026-06-01T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Sjögren’s Disease: Seeking Answers from More Than 90 Years of Research]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/daraxonrasib-s-moa-it-is-a-sticky-business</loc><lastmod>2026-05-31T19:17:00Z</lastmod><news:news><news:publication_date>2026-05-31T19:17:00Z</news:publication_date>
        <news:title><![CDATA[Daraxonrasib's MOA: It is a sticky business | ASCO 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/pembrolizumab-benefits-persist-at-nearly-8-years-in-tnbc-asco-2026</loc><lastmod>2026-05-31T18:28:09.078Z</lastmod><news:news><news:publication_date>2026-05-31T18:28:09.078Z</news:publication_date>
        <news:title><![CDATA[Pembrolizumab benefits persist at nearly 8 years in TNBC | ASCO 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/early-data-show-vaccine-has-potential-to-prevent-lynch-related-cancers-asco-2026</loc><lastmod>2026-05-31T16:45:00Z</lastmod><news:news><news:publication_date>2026-05-31T16:45:00Z</news:publication_date>
        <news:title><![CDATA[Early data show vaccine has potential to prevent Lynch-related cancers | ASCO 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/asco-awards-eduardo-vilar-sanchez-m-d-ph-d-for-cancer-prevention-research-asco-2026</loc><lastmod>2026-05-31T16:30:00Z</lastmod><news:news><news:publication_date>2026-05-31T16:30:00Z</news:publication_date>
        <news:title><![CDATA[ASCO awards Eduardo Vilar-Sanchez, M.D., Ph.D., for cancer prevention research | ASCO 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/favorable-phase-3-results-for-daraxonrasib-heralded-as-a-grand-slam-2026-asco</loc><lastmod>2026-05-31T12:01:19.623Z</lastmod><news:news><news:publication_date>2026-05-31T12:01:19.623Z</news:publication_date>
        <news:title><![CDATA[Favorable phase 3 results for pancreatic cancer drug daraxonrasib heralded as a 'grand slam'| ASCO 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/daraxonrasib-second-line-pancreatic-cancer-treatment-truly-remarkable-2026-asco</loc><lastmod>2026-06-01T21:07:00.000Z</lastmod><news:news><news:publication_date>2026-05-31T12:01:00Z</news:publication_date>
        <news:title><![CDATA[Daraxonrasib, second-line pancreatic cancer treatment, 'truly remarkable' | 2026 ASCO]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/ivonescimab-reduced-the-risk-of-death-by-34-in-squamous-nsclc-asco-2026</loc><lastmod>2026-05-31T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-31T12:00:00Z</news:publication_date>
        <news:title><![CDATA[ Ivonescimab reduced the risk of death by 34% in squamous NSCLC | ASCO 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/new-trial-results-point-toward-a-more-targeted-approach-to-metastatic-castration-sensitive-prostate-cancer-asco-2026</loc><lastmod>2026-05-30T22:30:00Z</lastmod><news:news><news:publication_date>2026-05-30T22:30:00Z</news:publication_date>
        <news:title><![CDATA[New trial results point toward a more targeted approach to metastatic castration-sensitive prostate cancer | ASCO 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/alicia-morgans-md-on-cognitive-outcomes-in-the-aracog-trial-asco-2026</loc><lastmod>2026-05-30T22:00:00Z</lastmod><news:news><news:publication_date>2026-05-30T22:00:00Z</news:publication_date>
        <news:title><![CDATA[Alicia Morgans, M.D., on cognitive outcomes in the ARACOG trial | ASCO 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/results-of-new-lung-cancer-combination-treatment-are-highly-promising-asco-2026</loc><lastmod>2026-05-30T21:01:00Z</lastmod><news:news><news:publication_date>2026-05-30T21:01:00Z</news:publication_date>
        <news:title><![CDATA[Results of new lung cancer combination treatment are “highly promising” | ASCO 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/the-next-steps-for-this-investigational-lung-cancer-treatment-asco-2026</loc><lastmod>2026-05-30T21:01:00Z</lastmod><news:news><news:publication_date>2026-05-30T21:01:00Z</news:publication_date>
        <news:title><![CDATA[The next steps for this investigational lung cancer treatment | ASCO 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/chemotherapy-free-drug-combination-shows-promise-for-patients-with-kras-positive-lung-cancer-asco-2026</loc><lastmod>2026-05-30T21:01:00Z</lastmod><news:news><news:publication_date>2026-05-30T21:01:00Z</news:publication_date>
        <news:title><![CDATA[Chemotherapy-free drug combination shows promise for patients with KRAS-positive lung cancer | ASCO 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/coverage-gaps-exist-for-molecular-testing-of-children-s-cancers-asco-2026</loc><lastmod>2026-05-29T18:05:00.000Z</lastmod><news:news><news:publication_date>2026-05-30T13:32:09.400Z</news:publication_date>
        <news:title><![CDATA[Coverage gaps exist for molecular testing of children’s cancers | ASCO 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/radiation-implant-outperforms-traditional-radiation-for-brain-metastases-asco-2026</loc><lastmod>2026-05-30T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-30T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Radiation implant outperforms traditional radiation for brain metastases | ASCO 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/new-molecular-biomarkers-have-potential-to-transform-pediatric-cancer-asco-2026</loc><lastmod>2026-05-29T18:00:00Z</lastmod><news:news><news:publication_date>2026-05-29T18:00:00Z</news:publication_date>
        <news:title><![CDATA[New molecular biomarkers have potential to transform pediatric cancer | ASCO 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/clinician-voices-and-facts-drive-vaccine-related-social-media-engagement</loc><lastmod>2026-05-29T17:50:45.846Z</lastmod><news:news><news:publication_date>2026-05-29T17:50:45.846Z</news:publication_date>
        <news:title><![CDATA[Clinician voices and facts drive vaccine-related social media engagement]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/lorbrena-shows-persistent-pfs-benefit-at-7-years-in-alk-nsclc-asco-2026</loc><lastmod>2026-05-29T17:25:33.410Z</lastmod><news:news><news:publication_date>2026-05-29T17:25:33.410Z</news:publication_date>
        <news:title><![CDATA[Lorbrena shows persistent PFS benefit at 7 years in ALK+ NSCLC | ASCO 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/fda-approves-afrezza-for-children-and-adolescents-with-diabetes</loc><lastmod>2026-05-29T17:24:52.169Z</lastmod><news:news><news:publication_date>2026-05-29T17:24:52.169Z</news:publication_date>
        <news:title><![CDATA[FDA approves Afrezza for children and adolescents with diabetes ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/carveouts-in-healthcare-safety-net-reform-risk-empowering-middlemen</loc><lastmod>2026-05-28T11:33:12.599Z</lastmod><news:news><news:publication_date>2026-05-28T11:33:12.599Z</news:publication_date>
        <news:title><![CDATA[Carveouts in healthcare safety net reform risk empowering middlemen]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/cvs-caremark-to-put-zepbound-back-on-formulary-and-add-foundayo</loc><lastmod>2026-05-28T11:26:33.340Z</lastmod><news:news><news:publication_date>2026-05-28T11:26:33.340Z</news:publication_date>
        <news:title><![CDATA[CVS Caremark to put Zepbound back on formulary and add Foundayo]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/takeaways-about-bispecific-antibodies</loc><lastmod>2026-05-27T12:05:00Z</lastmod><news:news><news:publication_date>2026-05-27T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Takeaways about bispecific antibodies]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/operational-challenges-for-health-systems-and-managing-side-effects</loc><lastmod>2026-05-27T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-27T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Operational challenges for health systems and managing side effects]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/eli-lilly-acquires-three-vaccine-companies-for-infectious-disease-portfolio</loc><lastmod>2026-05-26T19:07:00Z</lastmod><news:news><news:publication_date>2026-05-26T19:07:00Z</news:publication_date>
        <news:title><![CDATA[Eli Lilly acquires three vaccine companies for infectious disease portfolio]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/time-for-a-new-car-smell-for-managing-cell-and-gene-therapy-costs</loc><lastmod>2026-05-26T18:14:00Z</lastmod><news:news><news:publication_date>2026-05-26T18:14:00Z</news:publication_date>
        <news:title><![CDATA[Time for a 'new car smell' for managing cell and gene therapy costs]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/specialty-pharmacy-explained-growth-pricing-and-industry-economics</loc><lastmod>2026-05-26T18:00:00Z</lastmod><news:news><news:publication_date>2026-05-26T18:00:00Z</news:publication_date>
        <news:title><![CDATA[Specialty Pharmacy, Explained: Growth, Pricing and Industry Economics ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/efimosfermin-wins-key-designations-from-fda-ema</loc><lastmod>2026-05-26T16:30:00Z</lastmod><news:news><news:publication_date>2026-05-26T16:30:00Z</news:publication_date>
        <news:title><![CDATA[Efimosfermin wins key designations from FDA, EMA]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/a-milestone-in-vitiligo-clinical-efficacy-and-long-term-repigmentation-trends</loc><lastmod>2026-05-25T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-25T12:00:00Z</news:publication_date>
        <news:title><![CDATA[A Milestone in Vitiligo: Clinical Efficacy and Long-Term Repigmentation Trends ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/langlara-third-interchangeable-biosimilar-to-lantus-approved-by-fda</loc><lastmod>2026-05-24T14:17:00Z</lastmod><news:news><news:publication_date>2026-05-24T14:17:00Z</news:publication_date>
        <news:title><![CDATA[Langlara, third interchangeable biosimilar to Lantus, approved by FDA]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/fda-approves-first-treatment-for-chronic-hepatitis-delta-virus</loc><lastmod>2026-05-22T20:32:00.931Z</lastmod><news:news><news:publication_date>2026-05-22T20:32:00.931Z</news:publication_date>
        <news:title><![CDATA[FDA approves first treatment for chronic hepatitis D virus]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/nubeqa-edges-xtandi-on-cognitive-side-effects-asco-2026</loc><lastmod>2026-05-21T22:03:32.649Z</lastmod><news:news><news:publication_date>2026-05-21T22:03:32.649Z</news:publication_date>
        <news:title><![CDATA[Nubeqa edges Xtandi on cognitive side effects | ASCO 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/ovarian-cancer-response-to-chemotherapy-may-improve-with-fasting-asco-2026</loc><lastmod>2026-05-21T21:01:00Z</lastmod><news:news><news:publication_date>2026-05-21T21:01:00Z</news:publication_date>
        <news:title><![CDATA[Ovarian cancer response to chemotherapy may improve with fasting | ASCO 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/cancer-patients-taking-glp-1s-less-likely-to-develop-advanced-disease-asco-2026</loc><lastmod>2026-05-21T21:01:00Z</lastmod><news:news><news:publication_date>2026-05-21T21:01:00Z</news:publication_date>
        <news:title><![CDATA[Cancer patients taking GLP-1s less likely to develop advanced disease   | ASCO 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/priority-review-granted-for-kerendia-in-type-1-diabetes-and-kidney-disease</loc><lastmod>2026-05-21T18:38:46.940Z</lastmod><news:news><news:publication_date>2026-05-21T18:38:46.940Z</news:publication_date>
        <news:title><![CDATA[Priority review granted for Kerendia in Type 1 diabetes and kidney disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/gains-yes-but-only-1-in-4-who-are-eligible-get-screened-for-lung-cancer</loc><lastmod>2026-05-21T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-21T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Gains, yes. But only 1 in 4 who are eligible get screened for lung cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/recent-covid-vaccination-cuts-household-transmission-by-half</loc><lastmod>2026-05-20T19:36:55.862Z</lastmod><news:news><news:publication_date>2026-05-20T19:36:55.862Z</news:publication_date>
        <news:title><![CDATA[Recent COVID vaccination cuts household transmission by half]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/a-conversation-about-the-latest-discovery-about-narcoleptic-brains-with-sleep-researcher-jerome-siegel-ph-d-</loc><lastmod>2026-05-20T18:45:00Z</lastmod><news:news><news:publication_date>2026-05-20T18:45:00Z</news:publication_date>
        <news:title><![CDATA[A conversation exploring the newest discovery in narcolepsy research, with sleep researcher Jerome Siegel, Ph.D.]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/family-healthcare-costs-reach-37-824-analysis-finds</loc><lastmod>2026-05-20T18:26:29.789Z</lastmod><news:news><news:publication_date>2026-05-20T18:26:29.789Z</news:publication_date>
        <news:title><![CDATA[Family healthcare costs reach $37,824, analysis finds ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/historical-37-increase-in-affordable-care-act-deductible-rates</loc><lastmod>2026-05-20T16:50:00Z</lastmod><news:news><news:publication_date>2026-05-20T16:50:00Z</news:publication_date>
        <news:title><![CDATA[Historic 37% increase in Affordable Care Act deductible rates ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/alecensa-maintains-survival-edge-in-alk-nsclc-study-finds</loc><lastmod>2026-05-20T16:47:00Z</lastmod><news:news><news:publication_date>2026-05-20T16:47:00Z</news:publication_date>
        <news:title><![CDATA[Alecensa has survival edge in ALK+ NSCLC, Study Finds]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/the-value-and-cost-effectiveness-of-bispecific-antibodies</loc><lastmod>2026-05-20T12:05:00Z</lastmod><news:news><news:publication_date>2026-05-20T12:05:00Z</news:publication_date>
        <news:title><![CDATA[The value and cost-effectiveness of bispecific antibodies]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/takeaways-from-the-phase-1-2-linker-mm4-and-other-ongoing-trials-of-early-line-bispecific-antibody-treatment</loc><lastmod>2026-05-20T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-20T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Takeaways from the phase 1/2 LINKER-MM4 and other ongoing trials of early-line bispecific antibody treatment]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/sunscreen-can-have-a-hefty-price-tag-study-finds</loc><lastmod>2026-05-18T18:37:05.126Z</lastmod><news:news><news:publication_date>2026-05-18T18:37:05.126Z</news:publication_date>
        <news:title><![CDATA[Sunscreen can have a hefty price tag, study finds]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/navitus-sharon-faust-talks-about-trends-in-glp-1-spend</loc><lastmod>2026-05-18T17:29:08.234Z</lastmod><news:news><news:publication_date>2026-05-18T17:29:08.234Z</news:publication_date>
        <news:title><![CDATA[Navitus’ Sharon Faust talks about trends in GLP-1 spend]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/psychosocial-impacts-and-traditional-treatment-modalities-in-vitiligo</loc><lastmod>2026-05-18T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-18T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Psychosocial Impacts and Traditional Treatment Modalities in Vitiligo]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/fda-approves-first-biosimilars-interchangeable-with-simponi-simponi-aria</loc><lastmod>2026-05-18T12:11:37.406Z</lastmod><news:news><news:publication_date>2026-05-15T21:02:47.365Z</news:publication_date>
        <news:title><![CDATA[ FDA approves first biosimilars interchangeable with Simponi/Simponi Aria]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/navitus-specialty-drugs-and-glp-1s-continue-to-drive-drug-trend</loc><lastmod>2026-05-15T15:16:47.700Z</lastmod><news:news><news:publication_date>2026-05-15T15:16:47.700Z</news:publication_date>
        <news:title><![CDATA[Navitus: Specialty drugs and GLP-1s continue to drive drug trend]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/aradigm-aims-high-shoots-for-bringing-payers-providers-patients-and-manufacturers-together-to-solve-cell-and-gene-therapy-access-financial-risk-problems</loc><lastmod>2026-05-15T12:20:00Z</lastmod><news:news><news:publication_date>2026-05-15T12:20:00Z</news:publication_date>
        <news:title><![CDATA[Aradigm aims high, shoots for bringing payers, providers, patients and manufacturers together to solve cell and gene therapy access, financial risk problems]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/car-t-has-landed-and-the-gene-therapies-need-a-bespoke-approach-says-aradigm-ceo-will-shrank-m-d-</loc><lastmod>2026-05-15T12:10:00Z</lastmod><news:news><news:publication_date>2026-05-15T12:10:00Z</news:publication_date>
        <news:title><![CDATA[CAR-T has 'landed,' and the gene therapies need a 'bespoke' approach, says Aradigm CEO Will Shrank, M.D.]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/cell-and-gene-therapies-are-incredible-but-pose-a-defining-challenge-for-u-s-healthcare-says-aradigm-ceo-will-shrank-m-d-</loc><lastmod>2026-05-15T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-15T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Cell and gene therapies are 'incredible' but pose a defining challenge for U.S. healthcare, says Aradigm CEO Will Shrank, M.D.]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/fda-approves-two-treatments-for-rare-blood-cancers-in-same-week</loc><lastmod>2026-05-14T17:53:55.066Z</lastmod><news:news><news:publication_date>2026-05-14T17:53:55.066Z</news:publication_date>
        <news:title><![CDATA[FDA approves two treatments for rare blood cancers in same week]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/sleeping-too-much-and-too-little-associated-with-premature-aging</loc><lastmod>2026-05-14T17:20:00Z</lastmod><news:news><news:publication_date>2026-05-14T17:20:00Z</news:publication_date>
        <news:title><![CDATA[Sleeping too much (and too little) associated with premature aging]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/pain-affecting-daily-life-often-goes-undiagnosed</loc><lastmod>2026-05-13T21:15:27.643Z</lastmod><news:news><news:publication_date>2026-05-13T21:15:27.643Z</news:publication_date>
        <news:title><![CDATA[Pain affecting daily life often goes undiagnosed]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/financial-instability-strongly-linked-to-poor-art-adherence-in-young-people-with-hiv</loc><lastmod>2026-05-13T19:55:00Z</lastmod><news:news><news:publication_date>2026-05-13T19:55:00Z</news:publication_date>
        <news:title><![CDATA[Financial instability strongly linked to poor ART adherence in young people with HIV ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/faq-what-unitedhealthcare-s-prior-authorization-changes-could-ignite-for-the-industry</loc><lastmod>2026-05-13T16:15:00Z</lastmod><news:news><news:publication_date>2026-05-13T16:15:00Z</news:publication_date>
        <news:title><![CDATA[FAQ: What UnitedHealthcare’s prior authorization changes could ignite for the industry]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/semaglutide-offers-weight-loss-independent-benefits-in-mash</loc><lastmod>2026-05-13T13:01:35.217Z</lastmod><news:news><news:publication_date>2026-05-13T13:01:35.217Z</news:publication_date>
        <news:title><![CDATA[Semaglutide offers weight-loss-independent benefits in MASH]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/advantages-of-bispecific-antibodies-over-triplet-and-quadruplet-therapies</loc><lastmod>2026-05-13T12:05:00Z</lastmod><news:news><news:publication_date>2026-05-13T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Advantages of bispecific antibodies over triplet and quadruplet therapies]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/patients-who-would-benefit-from-early-line-treatment-bispecific-antibodies</loc><lastmod>2026-05-13T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-13T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Patients who would benefit from early-line treatment bispecific antibodies]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/overkill-higher-ivermectin-dose-less-effective-than-standard-dose-for-treating-severe-scabies</loc><lastmod>2026-05-12T20:14:00Z</lastmod><news:news><news:publication_date>2026-05-12T20:14:00Z</news:publication_date>
        <news:title><![CDATA[Overkill: Higher ivermectin dose less effective than standard dose for treating severe scabies  ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/clinical-utility-of-gemtesa-vibegron-in-diverse-managed-oab-populations</loc><lastmod>2026-05-12T20:00:05.556Z</lastmod><news:news><news:publication_date>2026-05-12T20:00:05.556Z</news:publication_date>
        <news:title><![CDATA[Clinical Utility of GEMTESA® (vibegron) in Diverse Managed OAB Populations]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/10-trends-managed-care-execs-shouldn-t-ignore-for-the-rest-of-2026</loc><lastmod>2026-05-12T20:00:00Z</lastmod><news:news><news:publication_date>2026-05-12T20:00:00Z</news:publication_date>
        <news:title><![CDATA[10 trends managed care execs shouldn’t ignore for the rest of 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/makary-is-resigning-as-fda-commissioner-say-multiple-news-reports</loc><lastmod>2026-05-13T02:05:06.560Z</lastmod><news:news><news:publication_date>2026-05-12T18:05:58.587Z</news:publication_date>
        <news:title><![CDATA[Makary out as FDA commissioner]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/nanoparticle-based-blood-test-outperforms-invasive-biopsy-for-pancreatic-cancer-detection</loc><lastmod>2026-05-12T15:58:34.837Z</lastmod><news:news><news:publication_date>2026-05-12T15:58:34.837Z</news:publication_date>
        <news:title><![CDATA[Nanoparticle-based blood test outperforms invasive biopsy for pancreatic cancer detection]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/madrigal-buys-right-to-rna-silencing-agent-that-could-be-coupled-with-rezdriffa</loc><lastmod>2026-05-12T15:14:00Z</lastmod><news:news><news:publication_date>2026-05-12T15:14:00Z</news:publication_date>
        <news:title><![CDATA[Madrigal buys right to RNA-interfering agent that could be coupled with its MASH drug, Rezdriffa]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/optum-rx-to-transition-to-flat-service-fee-model</loc><lastmod>2026-05-12T13:00:51.709Z</lastmod><news:news><news:publication_date>2026-05-12T13:00:51.709Z</news:publication_date>
        <news:title><![CDATA[Optum Rx to transition to flat service fee model]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/tumors-on-a-chip-may-lead-to-insights-into-pancreatic-cancer</loc><lastmod>2026-05-11T18:36:54.855Z</lastmod><news:news><news:publication_date>2026-05-11T18:36:54.855Z</news:publication_date>
        <news:title><![CDATA[Tumors on a chip may lead to insights into pancreatic cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/cms-0057-f-readiness-is-advancing-but-execution-risk-is-growing</loc><lastmod>2026-05-11T16:24:09.493Z</lastmod><news:news><news:publication_date>2026-05-11T16:24:09.493Z</news:publication_date>
        <news:title><![CDATA[CMS‑0057‑F readiness Is advancing, but execution risk Is growing]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/injecting-immunotherapy-directly-into-melanoma-tumors-reduced-severe-toxicity-in-early-trial</loc><lastmod>2026-05-11T15:24:20.355Z</lastmod><news:news><news:publication_date>2026-05-11T15:24:20.355Z</news:publication_date>
        <news:title><![CDATA[Injecting immunotherapy directly into melanoma tumors reduced severe toxicity in early trial]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/foundayo-vs-oral-wegovy-13-things-you-should-know</loc><lastmod>2026-05-11T15:18:13.567Z</lastmod><news:news><news:publication_date>2026-05-11T15:18:13.567Z</news:publication_date>
        <news:title><![CDATA[Foundayo vs. oral Wegovy: 13 things you should know]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/understanding-the-pathogenesis-and-epidemiology-of-vitiligo</loc><lastmod>2026-05-11T15:15:00Z</lastmod><news:news><news:publication_date>2026-05-11T15:15:00Z</news:publication_date>
        <news:title><![CDATA[Understanding the Pathogenesis and Epidemiology of Vitiligo ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/our-conversation-with-will-shrank-m-d-</loc><lastmod>2026-05-11T14:58:01.774Z</lastmod><news:news><news:publication_date>2026-05-11T14:58:01.774Z</news:publication_date>
        <news:title><![CDATA[Our conversation with Will Shrank, M.D.]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/fight-over-hospital-prices-heats-up</loc><lastmod>2026-05-11T13:38:00Z</lastmod><news:news><news:publication_date>2026-05-11T13:38:00Z</news:publication_date>
        <news:title><![CDATA[Fight over hospital prices heats up]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/battle-of-the-bulge</loc><lastmod>2026-05-11T13:33:55.421Z</lastmod><news:news><news:publication_date>2026-05-11T13:33:55.421Z</news:publication_date>
        <news:title><![CDATA[Battle of the Bulge: May 2026 cover story]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/sensitive-skin-syndrome-biologically-distinct-from-rosacea</loc><lastmod>2026-05-08T17:23:00Z</lastmod><news:news><news:publication_date>2026-05-08T17:23:00Z</news:publication_date>
        <news:title><![CDATA[Sensitive skin syndrome biologically distinct from rosacea ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/fdafda-commissioner-marty-makary-is-getting-fired-according-to-news-reports-</loc><lastmod>2026-05-08T23:26:44.156Z</lastmod><news:news><news:publication_date>2026-05-08T17:21:36.183Z</news:publication_date>
        <news:title><![CDATA[FDA Commissioner Marty Makary is getting fired, according to news reports]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/glp-1-drugs-show-promise-in-cutting-costs-but-some-employers-consider-dropping-coverage</loc><lastmod>2026-05-08T15:15:39.863Z</lastmod><news:news><news:publication_date>2026-05-08T15:15:39.863Z</news:publication_date>
        <news:title><![CDATA[GLP-1 drugs show promise in cutting costs but some employers consider dropping coverage]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/dpyd-testing-moves-further-into-standard-oncology-care-after-guideline-updates</loc><lastmod>2026-05-07T18:00:00Z</lastmod><news:news><news:publication_date>2026-05-07T18:00:00Z</news:publication_date>
        <news:title><![CDATA[DPYD testing moves further into standard oncology care after guideline updates]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/your-brain-may-start-dreaming-before-you-fall-asleep-parisian-study-suggests</loc><lastmod>2026-05-07T16:48:00Z</lastmod><news:news><news:publication_date>2026-05-07T16:48:00Z</news:publication_date>
        <news:title><![CDATA[Your brain may start dreaming before you fall asleep, Parisian study suggests]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/rethinking-the-management-of-hemophilia-b</loc><lastmod>2026-05-07T15:31:34.813Z</lastmod><news:news><news:publication_date>2026-05-07T15:31:34.813Z</news:publication_date>
        <news:title><![CDATA[Rethinking the Management of Hemophilia B]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/payers-could-save-with-biosimilars-if-they-stop-chasing-rebates</loc><lastmod>2026-05-07T14:46:22.879Z</lastmod><news:news><news:publication_date>2026-05-07T14:46:22.879Z</news:publication_date>
        <news:title><![CDATA[Payers could save with biosimilars if they stop chasing rebates]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/a-novel-liquid-biopsy-could-transform-help-predict-which-breast-patients-will-respond-to-immunotherapy</loc><lastmod>2026-05-06T23:51:00Z</lastmod><news:news><news:publication_date>2026-05-06T23:51:00Z</news:publication_date>
        <news:title><![CDATA[A novel liquid biopsy could help predict which patients with breast cancer will respond to immunotherapy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/positive-results-for-hernexeos-as-a-first-line-treatment-for-her2-mutant-nsclc</loc><lastmod>2026-05-06T22:31:00Z</lastmod><news:news><news:publication_date>2026-05-06T22:31:00Z</news:publication_date>
        <news:title><![CDATA[Positive results for Hernexeos as a first-line treatment for HER2-mutant NSCLC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url></urlset>